Domini Impact Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$357K Sell
6,520
-3,724
-36% -$177K 4.7% 11
2019
Q3
$382K Buy
10,244
+80
+0.8% +$3.11K 5.93% 8
2019
Q2
$381K Sell
10,164
-32
-0.3% -$1.01K 5.29% 8
2019
Q1
$304K Sell
10,196
-40
-0.4% -$1.41K 4.66% 9
2018
Q4
$307K Sell
10,236
-4,156
-29% -$132K 6.19% 6
2018
Q3
$514K Hold
14,392
7.3% 2
2018
Q2
$342K Hold
14,392
5.9% 7
2018
Q1
$267K Buy
+14,392
New +$213K 5.24% 11

Other funds holding DXCM

Domini Impact Investments's DXCM Position: Q4 2019 in Review

Domini Impact Investments reduced its DexCom (DXCM) stake by 36% in Q4 2019, selling an estimated $177K and leaving 6,520 shares worth $357K. The position accounts for 4.7% of the portfolio, ranked #11.

Domini Impact Investments first reported a position in DXCM in Q1 2018 and has held it in 8 quarters since. The position peaked at $514K in Q3 2018. 508 funds tracked by Wall St. Rank hold DXCM as of Q4 2019.

  • Domini Impact Investments held 6,520 shares of DexCom worth $357K as of Q4 2019.
  • Domini Impact Investments sold 3,724 DexCom shares in Q4 2019, an estimated $177K.
  • DexCom made up 4.7% of Domini Impact Investments's portfolio in Q4 2019, its #11 holding.
  • Domini Impact Investments first reported a position in DexCom in Q1 2018 and has held it in 8 quarters since.
  • Domini Impact Investments's DexCom position peaked at $514K in Q3 2018.
  • 508 funds tracked by Wall St. Rank held DexCom as of Q4 2019.

Based on Domini Impact Investments's 13F filing for Q4 2019, filed 14 Feb 2020.